Genital Warts (Anogenital HPV) Treatment
Covered by Aetna in California

Imiquimod 5% cream applied once at bedtime 3 times per week for up to 16 weeks (per CDC STI Treatment Guidelines); wash treatment area with soap and water 6–10 hours after application. Apply to external visible warts only — not for internal (vaginal, cervical, anal) or urethral meatal warts. OR podofilox 0.5% solution or gel applied to warts twice daily × 3 days, followed by 4 days of no treatment, cycle repeated up to 4 cycles

Imiquimod 3.75% pump cream applied nightly for up to 8 weeks (requires PA under Aetna CA); sinecatechins 15% ointment (green tea extract) applied 3 times daily to external warts — NOT recommended for HIV-positive or immunocompromised patients; provider-administered options (cryotherapy, TCA 80–90%, surgical removal) for warts that don't respond to patient-applied therapy, large lesion burden, or cervical/vaginal/anal warts — these require in-person referral

Yes — generic imiquimod 5% cream is Tier 1 on Aetna CA, QL 2 boxes per 21 days; typically $15–$40 per box. Generic podofilox 0.5% solution is Tier 1 generic; typically $15–$30. Sinecatechins (Veregen) is Non-Formulary — patients needing sinecatechins pay out-of-pocket (typically $200+). Provider-administered procedures are covered under the procedural medical benefit with appropriate coding.

Podofilox and podophyllin are absolutely contraindicated in pregnancy. Imiquimod appears to pose low risk in pregnancy but CDC guidance recommends avoidance until more data are available — pregnant patients with genital warts are referred to in-person OB or dermatology. Genital wart treatment does not eliminate HPV infection or reduce future transmission risk — HPV clears naturally in most immunocompetent individuals within 1–2 years. HPV vaccination (Gardasil 9, up to age 45 per ACIP 2019) is discussed at the visit and covered by Aetna CA as preventive care. Warts at the urethral meatus, cervix, vagina, and anus require in-person provider-administered treatment. Recurrence after initial clearance is common (up to 30% in first 3 months), often reflecting persistent subclinical virus rather than treatment failure.

No. Patient-applied medications like imiquimod and podofilox are only appropriate for externally visible anogenital warts that the patient can see and apply treatment to directly. Internal warts — on the cervical epithelium, vaginal walls, or within the anal canal — require provider-administered procedures: cryotherapy with liquid nitrogen, trichloroacetic acid (TCA 80–90%), or surgical removal. Dr. Bhavsar will refer you to an in-person gynecologist, dermatologist, or colorectal surgeon for internal wart evaluation. TDMD treats the external component while you arrange the in-person referral.

Yes. Generic imiquimod 5% cream is a Tier 1 generic on the Aetna CA formulary with a quantity limit of 2 boxes per 21 days — enough for the full CDC-recommended 16-week course. The 2-box QL per 21 days allows adequate supply for typical treatment duration. Generic imiquimod is bioequivalent to brand Aldara and equally effective. Sinecatechins (Veregen) and brand Zyclara are Non-Formulary on standard plans; Dr. Bhavsar will prescribe the covered generic imiquimod or podofilox alternatives.

Treating genital warts removes visible lesions but does not eliminate the underlying HPV infection. HPV 6 and HPV 11 (the types that cause most genital warts) are typically cleared by the immune system within 1–2 years in immunocompetent individuals, regardless of wart treatment. Treatment eliminates visible warts, reduces viral shedding from treated areas, and improves comfort and cosmesis. Recurrence within the first 3 months after treatment occurs in up to 30% of patients, usually from persistent subclinical virus — this does not mean treatment failed. Discussing HPV vaccination status at the visit is important: even if you already have one HPV strain, Gardasil 9 covers 9 strains and may protect against additional types you haven't been exposed to.

Yes, partners with genital warts should be evaluated and treated. California's expedited partner therapy (EPT) law does not apply to HPV/genital warts because EPT covers bacterial STIs (chlamydia, gonorrhea, trichomoniasis) only — there is no antibiotic to prescribe for a viral infection. Partners should schedule their own clinical visit. Both current and prior partners may have been exposed: HPV incubation from exposure to visible wart development is typically 3 weeks to 8 months, making partner tracing more complex than for bacterial STIs. TDMD can provide a clinical note documenting your diagnosis to facilitate your partner's own visit.

Yes. Aetna commercial plans cover telehealth visits for Genital Warts (Anogenital HPV) in California. TeleDirectMD (Dr. Parth Bhavsar, MD, NPI: 1104323203) is an in-network telehealth provider with Aetna in California. Your standard Aetna telehealth copay applies — typically $10–$40 for most commercial plans. If clinically appropriate, your prescription is sent to your California pharmacy immediately after your visit.

Most Aetna commercial plans in California have telehealth copays of $10–$40. Often $0–$20 for employer plans. Your exact cost depends on your specific plan and whether your deductible has been met. Log into your Aetna member portal or call the member services number on your card to verify your telehealth copay before your genital warts treatment visit. Self-pay is always available for a flat $49 if you prefer to skip insurance.

If your specific Aetna plan is not in-network with TeleDirectMD in California, or if your deductible has not yet been met, you can book as a self-pay patient for a flat $49 fee — same physician, same quality of care, no insurance needed. You may also be eligible to submit an out-of-network claim to Aetna for partial reimbursement depending on your plan's out-of-network benefit.

TeleDirectMD typically offers same-day and next-day video visits. Book at teledirectmd.com/book-online and select a time that works for you. Most patients are seen within a few hours of booking during business hours. Your genital warts treatment symptoms are evaluated by Dr. Bhavsar, MD — not a nurse practitioner or PA — ensuring you receive a board-certified clinical assessment.

Yes. TeleDirectMD is operated by Dr. Parth Bhavsar, MD (NPI: 1104323203), a board-certified Family Medicine physician. TeleDirectMD is LegitScript certified, HIPAA compliant, and is contracted as an in-network telehealth provider with Aetna in California. Claims are billed using standard CPT codes (99213/99214) and submitted electronically to Aetna.

Yes. Telehealth visits with a licensed physician are qualified medical expenses eligible for FSA (Flexible Spending Account) and HSA (Health Savings Account) payment. If your Aetna plan applies your deductible first, your FSA or HSA card can be used to pay your portion. The $49 self-pay option is also FSA/HSA eligible.